Prediction and Identification of GPCRs Targeting for Drug Repurposing in Osteosarcoma.

Front Oncol · 2022 · PMC9021700 · PMID 35463319

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

close to significanceP = 0.057so close (0.05 < p ≤ 0.1)

In addition, it’s may note that the expression of GPR158 in non-metastatic-OS was seemed higher than the metastatic-OS (P = 0.057, close to significance).

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.